BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37398419)

  • 21. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.
    Jiang T; Collins BJ; Jin N; Watkins DN; Brock MV; Matsui W; Nelkin BD; Ball DW
    Cancer Res; 2009 Feb; 69(3):845-54. PubMed ID: 19176379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
    Moncho-Amor V; Pintado-Berninches L; Ibañez de Cáceres I; Martín-Villar E; Quintanilla M; Chakravarty P; Cortes-Sempere M; Fernández-Varas B; Rodriguez-Antolín C; de Castro J; Sastre L; Perona R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells.
    Wang XD; Hu R; Ding Q; Savage TK; Huffman KE; Williams N; Cobb MH; Minna JD; Johnson JE; Yu Y
    Nat Commun; 2019 Jul; 10(1):3201. PubMed ID: 31324758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor.
    Kim G; Kim M; Nam EJ; Lee JY; Park E
    Am J Surg Pathol; 2024 Mar; 48(3):364-372. PubMed ID: 37981832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of DUSP6 impairs infectious bronchitis virus replication by negatively regulating ERK pathway and promoting apoptosis.
    Wang H; Liu D; Sun Y; Meng C; Tan L; Song C; Qiu X; Liu W; Ding C; Ying L
    Vet Res; 2021 Jan; 52(1):7. PubMed ID: 33431056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
    Wan J; Wu W
    J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer.
    Lee JU; Huang S; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Kim SY; Joung KH; Kim JM; Shong M; Jo YS
    Eur J Endocrinol; 2012 Jul; 167(1):93-101. PubMed ID: 22535643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
    Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
    Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
    Phuchareon J; McCormick F; Eisele DW; Tetsu O
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China.
    Hu C; Dong J; Liu L; Liu J; Sun X; Teng F; Wang X; Ying J; Li J; Xing P; Yang L
    Thorac Cancer; 2022 Feb; 13(3):338-345. PubMed ID: 34931456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erk/MAP kinase signaling pathway and neuroendocrine differentiation of non-small-cell lung cancer.
    Chen Y; Nowak I; Huang J; Keng PC; Sun H; Xu H; Wei G; Lee SO
    J Thorac Oncol; 2014 Jan; 9(1):50-8. PubMed ID: 24346093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
    Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
    Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transcriptional regulation of the DUSP6/MKP-3 phosphatase by MEK/ERK signaling and hypoxia.
    Bermudez O; Jouandin P; Rottier J; Bourcier C; Pagès G; Gimond C
    J Cell Physiol; 2011 Jan; 226(1):276-84. PubMed ID: 20665674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
    Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
    Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-expression of Achaete-Scute Homologue-1 and Calcitonin Gene-Related Peptide during NNK-Induced Pulmonary Neuroendocrine Hyperplasia and Carcinogenesis in Hamsters.
    Naizhen X; Linnoila RI; Kimura S
    J Cancer; 2016; 7(14):2124-2131. PubMed ID: 27877229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation.
    Alam SK; Wang L; Ren Y; Hernandez CE; Kosari F; Roden AC; Yang R; Hoeppner LH
    Br J Cancer; 2020 Sep; 123(5):819-832. PubMed ID: 32499571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.
    Fushimi A; Morimoto Y; Ishikawa S; Yamashita N; Bhattacharya A; Daimon T; Rajabi H; Jin C; Hagiwara M; Yasumizu Y; Luan Z; Suo W; Wong KK; Withers H; Liu S; Long MD; Kufe D
    Mol Cancer Res; 2022 Sep; 20(9):1379-1390. PubMed ID: 35612556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.